RARE - Ultragenyx Pharmaceutical prices $300 million securities offering
2023-10-19 06:36:22 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx: Market Expectations Revised Lower, Awaiting Clinical Trial Catalysts (Rating Downgrade)
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical
- Historical earnings data for Ultragenyx Pharmaceutical
- Financial information for Ultragenyx Pharmaceutical
For further details see:
Ultragenyx Pharmaceutical prices $300 million securities offering